Examining respiratory and heart changes in COPD patients
Official title: The Impact of Dual Bronchodilation on Respiratory and Cardiovascular Systems in Patients With Newly Diagnosed Moderate-to-severe Chronic Obstructive Pulmonary Disease
Run by Lithuanian University of Health Sciences · NCT06072690 · Data updated 2026-11-12
This study looks at how chronic obstructive pulmonary disease (COPD) affects heart health and quality of life in people aged 40 and older with moderate to severe COPD.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Lithuanian University of Health Sciences Academic / other |
| Locations | 1 site (Kaunas, Kaunas County) |
| Status | Recruiting |
| Started | April 15, 2021 |
| Main results expected | August 31, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | April 2, 2026 |
| Trial ID | NCT06072690 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 40 and older with a smoking history of at least 10 pack-years and newly diagnosed moderate to severe COPD.
✕Probably not a fit
Patients with active lung infections, certain types of lung cancer, or other significant comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the relationship between chronic obstructive pulmonary disease (COPD) and cardiovascular diseases (CVDs) in patients aged 40 and older. It aims to understand how COPD affects cardiac function and quality of life, particularly focusing on patients with moderate to severe COPD. The study will assess various factors, including lung function and cardiovascular health, to better understand the interplay between these conditions. By identifying these relationships, the study hopes to highlight the importance of addressing cardiovascular health in COPD management.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with COPD, potentially enhancing their cardiovascular health and overall quality of life.
How similar studies have gone: While the relationship between COPD and cardiovascular health has been explored, this specific observational approach focusing on dual bronchodilation effects is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 40 years and older * Smoking index of 10 pack-years and more * Newly diagnosed chronic obstructive pulmonary disease (COPD) with forced expiratory volume in 1 second (FEV1) 30-79 percent of predicted and forced expiratory volume in 1 second to forced vital capacity ratio (FEV1/FVC) less than 70 percent of predicted. Exclusion Criteria: * Active lung infection * Present or previously treated lung cancer * Alpha-1 antitrypsin deficiency * Diagnosed interstitial lung disease * Previously diagnosed asthma * Diagnosed chronic hypercapnic respiratory failure * Treatment with systemic glucocorticoids * Unstable ischaemic heart disease * Pregnancy * Present cardiac arrhythmias * Uncontrolled arterial hypertension * Dementia and other mental states that determine patient's inability to consent * Other medical conditions that in the opinion of the investigator disqualify the subject for inclusion
Where it's running
-
Lithuanian University of Health Sciences
Kaunas, Kaunas County, Lithuania Recruiting
Study contacts
- Principal investigator: Skaidrius Miliauskas, PhD, Prof. — Lithuanian University of Health Sciences, Medical Academy, Department of Pulmonology
- Study coordinator: Skaidrius Miliauskas, PhD, Prof.
- Email: skaidrius.miliauskas@lsmu.lt
- Phone: +37037326269
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
One-stop photon-counting CT for patients after PCI
This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.